{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:10:21Z","timestamp":1775099421825,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","funder":[{"name":"American University of Beirut Medical Practice Plan (MPP)","award":["MPP320046, MPP320061"],"award-info":[{"award-number":["MPP320046, MPP320061"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2015.00215","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T05:11:01Z","timestamp":1444713061000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients"],"prefix":"10.3389","volume":"5","author":[{"given":"Joelle","family":"Makoukji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Raad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Genadry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"El-Sitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine J.","family":"Makhoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab","family":"Saad Aldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden","family":"Nohra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajanthah","family":"Sangaralingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Chelala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Boulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arafat","family":"Tfayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose-Mary","family":"Boustany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/S1470-2045(11)70323-0","article-title":"Breast cancer in Brazil: present status and future goals","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp0708307","article-title":"\u201cWesternizing\u201d women\u2019s risks? Breast cancer in lower-income countries","volume":"358","author":"Porter","year":"2008","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/S0140-6736(07)61697-3","article-title":"Scaling up interventions for chronic disease prevention: the evidence","volume":"370","author":"Gaziano","year":"2007","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(07)61700-0","article-title":"Action, prevention of chronic diseases: a call to action","volume":"370","author":"Beaglehole","year":"2007","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijsu.2006.06.015","article-title":"Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis","volume":"5","author":"El Saghir","year":"2007","journal-title":"Int J Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejon.2009.08.003","article-title":"Living with breast cancer, a Lebanese experience","volume":"14","author":"Doumit","year":"2010","journal-title":"Eur J Oncol Nurs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.canep.2010.02.013","article-title":"Breast cancer in Lebanon: incidence and comparison to regional and Western countries","volume":"34","author":"Lakkis","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"B8","first-page":"S1","article-title":"Breast cancer in Lebanon. Increased age-adjusted incidence rates in younger-aged groups at presentation: implications for screening and for Arab-American ethnic groups","volume":"15","author":"El Saghir","year":"2005","journal-title":"Ethn Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1203\/PDR.0b013e31816fdc17","article-title":"CLN3p impacts galactosylceramide transport, raft morphology, and lipid content","volume":"63","author":"Rusyn","year":"2008","journal-title":"Pediatr Res"},{"key":"B10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium","volume":"82","author":"Lerner","year":"1995","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10495-005-0733-6","article-title":"Cell death pathways in juvenile Batten disease","volume":"10","author":"Persaud-Sawin","year":"2005","journal-title":"Apoptosis"},{"key":"B12","first-page":"801","article-title":"The CLN3 gene is a novel molecular target for cancer drug discovery","volume":"62","author":"Rylova","year":"2002","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1203\/pdr.0b013e31802d8a4a","article-title":"Neuronal ceroid lipofuscinosis: a common pathway?","volume":"61","author":"Persaud-Sawin","year":"2007","journal-title":"Pediatr Res"},{"key":"B14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/153537020322800903","article-title":"Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system","volume":"228","author":"Simstein","year":"2003","journal-title":"Exp Biol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9836-9","article-title":"Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer","volume":"112","author":"Ruckhaberle","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"B17","volume-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Methodol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/mgme.1999.2834","article-title":"CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide","volume":"66","author":"Puranam","year":"1999","journal-title":"Mol Genet Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1746-1596-8-129","article-title":"Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes","volume":"8","author":"Cheng","year":"2013","journal-title":"Diagn Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine","volume":"14","author":"Ross","year":"2009","journal-title":"Oncologist"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","article-title":"Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group","volume":"23","author":"Marty","year":"2005","journal-title":"J Clin Oncol"},{"key":"B26","first-page":"43","article-title":"HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications","volume":"11","author":"Baselga","year":"1997","journal-title":"Oncology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molmed.2007.06.002","article-title":"Translational aspects of sphingolipid metabolism","volume":"13","author":"Zeidan","year":"2007","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1158\/0008-5472.CAN-11-3069","article-title":"Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer","volume":"72","author":"Heering","year":"2012","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1054\/drup.2001.0225","article-title":"Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance","volume":"4","author":"Ogretmen","year":"2001","journal-title":"Drug Resist Updat"},{"key":"B31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett"},{"key":"B32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2009.11.035","article-title":"Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression","volume":"391","author":"Erez-Roman","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"22432","DOI":"10.1074\/jbc.272.36.22432","article-title":"Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide","volume":"272","author":"Michel","year":"1997","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38069","DOI":"10.1074\/jbc.M111.297994","article-title":"Dihydroceramide-based response to hypoxia","volume":"286","author":"Devlin","year":"2011","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16718","DOI":"10.1074\/jbc.M700647200","article-title":"Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells","volume":"282","author":"Kraveka","year":"2007","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1182\/blood-2007-10-113068","article-title":"Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1172\/JCI65188","article-title":"Liver acid sphingomyelinase inhibits growth of metastatic colon cancer","volume":"123","author":"Osawa","year":"2013","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1158\/1541-7786.MCR-07-2097","article-title":"Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies","volume":"6","author":"Corcoran","year":"2008","journal-title":"Mol Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.bjc.6605750","article-title":"Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases","volume":"103","author":"Dziegiel","year":"2010","journal-title":"Br J Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1200\/JCO.2006.06.8809","article-title":"Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients","volume":"24","author":"van Geelen","year":"2006","journal-title":"J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s001090050128","article-title":"Multistep carcinogenesis of breast cancer and tumour heterogeneity","volume":"75","author":"Beckmann","year":"1997","journal-title":"J Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e86952","DOI":"10.1371\/journal.pone.0086952","article-title":"High levels of BCOX1 expression are associated with poor prognosis in patients with invasive ductal carcinomas of the breast","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbagen.2005.09.017","article-title":"Identification of BCOX1, a novel gene overexpressed in breast cancer","volume":"1760","author":"Song","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.bbagen.2005.09.017","article-title":"Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications","volume":"7","author":"Tabor","year":"2001","journal-title":"Clin Cancer Res"},{"key":"B45","first-page":"2718","article-title":"Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment","volume":"6","author":"Partridge","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.7326\/0003-4819-127-11-199712010-00013","article-title":"Ductal carcinoma in situ of the breast","volume":"127","author":"Fonseca","year":"1997","journal-title":"Ann Intern Med"},{"key":"B47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1052-5157(18)30294-0","article-title":"Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons","volume":"7","author":"Neugut","year":"1997","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1172\/JCI64791","article-title":"Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse","volume":"123","author":"Cheng","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T18:44:44Z","timestamp":1718131484000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2015.00215\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":48,"URL":"https:\/\/doi.org\/10.3389\/fonc.2015.00215","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}